Naudota literatūra kuriant produktą ir jo aprašymą:
[1] LEEMING, J. P.; HOLLAND, K. T.; BOJAR, R. A. The in vitro antimicrobial effect of azelaic acid. British Journal of Dermatology, 1986, 115.5: 551-556.
[2] SCHULTE, Brian C.; WU, Wesley; ROSEN, Ted. Azelaic acid: evidence-based update on mechanism of action and clinical application. Journal of drugs in dermatology: JDD, 2015, 14.9: 964-968.
[3] ZHU, Jieyu, et al. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery–a review. International journal of pharmaceutics, 2020, 578: 119127.
[4] KUMAR, Anil; RAO, Rekha; YADAV, Poonam. Azelaic acid: a promising agent for dermatological applications. Current Drug Therapy, 2020, 15.3: 181-193.
[5] ZHU, Jia, et al. Alleviating Skin Barrier Disruption, Skin Inflammation, and Pruritus: A Moisturizing Spray Containing β-Glucan and Panthenol. International Journal of Dermatology and Venereology, 2023, 6.01: 1-8.
[6] HOW, Kang Nien, et al. Hyaluronic acid-mediated drug delivery system targeting for inflammatory skin diseases: A mini review. Frontiers in Pharmacology, 2020, 11: 1105.
[7] BERARDESCA, Enzo; CAMELI, Norma. Vitamin E supplementation in inflammatory skin diseases. Dermatologic therapy, 2021, 34.6: e15160.
[8] SEARLE, Tamara; ALI, Faisal R.; AL-NIAIMI, Firas. The versatility of azelaic acid in dermatology. Journal of Dermatological Treatment, 2022, 33.2: 722-732.
[9] ZHANG, Xianghua, et al. Efficacy and safety of a panthenol‐enriched mask for individuals with distinct impaired skin barrier subtypes. Journal of Cosmetic Dermatology, 2024.
[10] BERARDESCA, Enzo; CAMELI, Norma. Vitamin E supplementation in inflammatory skin diseases. Dermatologic therapy, 2021, 34.6: e15160.